AcelRx Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ACRX) Q2 2022 Earnings Conference Call August 11, 2022, 04:30 PM ET Company Participants Raffi Asadorian - CFO Vincent Angotti - CEO Pamela.
Without knowledge of the DSUVIA deal it is hard to assess the prospect, so I retain a neutral rating with a tilt to buy. Read more about ACRX stock here.
AcelRx Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ACRX) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Raffi Asadorian - Chief Financial Officer Vincent Angotti -.
Interview with the CEO: AcelRx Pharmaceuticals, Inc (NASDAQ:ACRX) twst.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from twst.com Daily Mail and Mail on Sunday newspapers.